AI-assisted source summary. Read the scope and exceptions, then follow the original documents below.
Applies to
United States · dermal fillers and needle-free injection devices
Time context
FDA guidance checked October 20, 2026
Sources checked
US regulatory scope only. Approval varies by product and indication; other countries have different rules. Ask a licensed clinician about individual risks.
Needle-free does not mean FDA-approved
FDA says needle-free devices are not approved for injecting dermal fillers and that it has not approved fillers for over-the-counter use. It reports serious adverse events with needle-free devices. A 'non-invasive' sales label does not resolve those concerns.
FDA's approval page links to product-specific safety summaries and labeling. Approval depends on the product and anatomical use; it is not a blanket endorsement for every injection site or technique carrying the same brand name.
Our checklist: request the exact product, intended use, injector's credentials and complication plan in writing. Avoid self-injection products sold as an easy beauty hack. Read the original patient labeling rather than relying on a screenshot of an approval claim.
Original documents used for this summary. Multiple links from one publisher are not independent corroboration. Policies can change after the check date.
AI-assisted research, writing and translation by No Secrets, using the linked public documents. This is a source summary, not firsthand reporting or an independently audited investigation. No affiliate links are used in this article.
The date above records this research pass, not the date of every underlying event. The English and Chinese versions are AI-assisted summaries; the linked original controls if they differ.